Skip to content
Clinical Trials – home

ROHHAD syndrome Basic Information

1 / 1 trials open to patients1 country

In short

ROHHAD syndrome is an extremely rare and life-threatening disorder that affects children, causing rapid weight gain, breathing problems, and damage to multiple body systems. With fewer than 200 documented cases worldwide, this condition remains a medical mystery that challenges families and healthcare providers alike.

Key points

  • ROHHAD syndrome is extremely rare, with fewer than 200 documented cases worldwide, making it unlikely most doctors will ever encounter it during their careers.
  • Children are typically born healthy and develop normally until symptoms suddenly appear between ages 1 and 9, with rapid weight gain usually being the first warning sign.
  • The condition causes life-threatening breathing problems because the brain loses its automatic ability to control breathing, especially during sleep.
  • About half of children with ROHHAD develop tumors called ganglioneuromas or ganglioneuroblastomas, which are usually benign and treatable.
  • The exact cause remains unknown, though researchers are exploring genetic, epigenetic, and autoimmune theories to explain why this condition develops.
  • Without diagnosis and treatment, ROHHAD is fatal in 50 to 60 percent of cases, primarily due to cardiopulmonary arrest from untreated breathing problems.
  • Treatment is supportive rather than curative, requiring a team of specialists to manage breathing, hormonal problems, autonomic dysfunction, and other symptoms.
  • Early recognition and diagnosis are crucial for improving outcomes, though diagnosis is challenging because symptoms develop gradually and can resemble other conditions.

Understanding ROHHAD Syndrome

ROHHAD syndrome stands for Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation. This condition affects children who are typically healthy at birth and develop normally until symptoms suddenly appear, usually between the ages of 1 and 9 years. Most children begin showing signs between ages 2 and 4, though the timing can vary considerably from one child to another.

The condition was first described in 1965, making it a relatively new disorder in medical literature. Because ROHHAD is so rare and affects multiple body systems in different ways, it often takes years before doctors arrive at the correct diagnosis. Many children experience a long and difficult journey through numerous hospitals and specialists before anyone recognizes what is happening.

What makes ROHHAD particularly challenging is that every child presents differently. The timing of symptom onset varies, as does the severity and range of problems each child faces. Some researchers believe ROHHAD may not be a single condition but rather a collection of similar conditions with different underlying causes, which would explain why symptoms vary so widely.

How Common Is ROHHAD Syndrome?

ROHHAD syndrome is classified as an orphan disease, which typically refers to conditions affecting fewer than 1 in 2,000 people. The condition is exceptionally rare, with fewer than 200 documented cases worldwide according to most sources, though some reports suggest only around 100 to 158 confirmed cases globally.

The actual number of people affected may be higher than reported, as many cases likely go undiagnosed or are misdiagnosed as other conditions. Because the syndrome is so rare and its symptoms can resemble other disorders, healthcare providers may not consider ROHHAD as a possibility. One patient advocate noted that probably 95% of doctors and healthcare providers will never hear about ROHHAD during their careers, making proper diagnosis even more difficult.

The true incidence of ROHHAD syndrome in any population remains unknown. There is no clear pattern showing that the condition affects one gender more than another, nor is there evidence that it is more common in specific geographic regions or ethnic groups.

What Causes ROHHAD Syndrome?

The exact cause of ROHHAD syndrome remains unknown, which adds to the frustration and fear experienced by affected families. Despite ongoing research, scientists have not yet identified a definitive cause, though several theories are being explored.

One leading theory involves genetics. Many researchers believe that a genetic mutation causes ROHHAD syndrome, but despite extensive searching, no specific gene mutation has been identified. This makes genetic testing unhelpful for diagnosis at the current time.

Another theory focuses on epigenetics, which involves how genes turn on and off rather than mutations in the genes themselves. Some researchers believe that in certain cases, genes that manage important body functions can switch on or off unexpectedly. Support for this theory comes from a research study involving identical twins, where one twin developed ROHHAD syndrome while the other remained healthy, suggesting that something beyond inherited DNA might be involved.

The autoimmune theory has gained attention in recent years. Some experts believe ROHHAD may be a type of autoimmune condition called a paraneoplastic disease, where the immune system mistakenly attacks the body's own organs, particularly the brain and adrenal glands. Supporting this theory, researchers have found immunoglobulins (proteins produced by the immune system) in the cerebrospinal fluid (the fluid surrounding the brain and spinal cord) of children with ROHHAD, suggesting inflammation in the central nervous system (the brain and spinal cord).

Who Is at Risk for Developing ROHHAD Syndrome?

Unlike many medical conditions, ROHHAD syndrome does not have clearly identified risk factors that predict who will develop the disorder. Children with ROHHAD are typically born healthy with normal growth and development. There is no known family history pattern, meaning the condition does not appear to run in families in a predictable way.

The condition affects previously healthy children who show no signs of problems until symptoms begin appearing, usually between ages 1.5 and 11 years, with most cases starting between ages 2 and 4. Both boys and girls can develop ROHHAD, with no clear evidence that one gender is more susceptible than the other.

Because the cause remains unknown and no genetic marker has been identified, doctors cannot predict which children will develop ROHHAD syndrome. There are no known environmental factors, infections, or exposures that increase risk. The condition appears to strike randomly, which makes it particularly frightening for families who have no warning or family history to alert them to the possibility.

Recognizing the Symptoms of ROHHAD Syndrome

The symptoms of ROHHAD syndrome typically unfold in a specific sequence over time, though not every child experiences all symptoms or develops them in the same order. Understanding these symptoms is crucial because early recognition can lead to faster diagnosis and treatment.

Rapid-Onset Obesity

The first and most noticeable symptom is usually rapid and dramatic weight gain. Children typically gain 20 to 30 pounds over a period of just 6 to 12 months, accompanied by excessive hunger called hyperphagia. This weight gain is not related to overeating alone or lack of exercise but rather to changes in how the body regulates metabolism and appetite. A child's weight can jump from a normal percentile to the 99th percentile in less than a year.

Hypothalamic Dysfunction

The hypothalamus is a small but crucial part of the brain that controls the pituitary gland and regulates several vital body functions including growth, weight, appetite, puberty, emotions, and behavior. When hypothalamic dysfunction develops in ROHHAD, children may experience a wide range of problems.

These problems can include abnormally low or high sodium levels in the blood, which can be dangerous. Low sodium, called hyponatremia, can cause nausea, headache, seizures, or even coma. High sodium, called hypernatremia, can cause nausea, muscle weakness, altered mental status, or coma. Children may also develop irregular temperature regulation, diabetes insipidus (a condition causing excessive urination and dilute urine), hypothyroidism (low thyroid hormone), growth hormone insufficiency leading to short stature, and problems with puberty that arrives either too early or too late.

Hypoventilation

Hypoventilation refers to breathing that is not adequate to meet the body's needs. In ROHHAD, the brain loses its normal automatic control of breathing. Children cannot properly regulate their breathing in response to daily activities like exercise, sleep, or eating. Their bodies do not automatically take deeper or faster breaths when oxygen levels are low and carbon dioxide levels are high.

This breathing problem is particularly dangerous during sleep, when automatic breathing control is most important. In some children, hypoventilation can initially present as respiratory failure following a mild respiratory illness such as a cold or after receiving anesthesia for a medical procedure. Without proper treatment with mechanical ventilation, hypoventilation can lead to life-threatening complications.

Autonomic Dysregulation

The autonomic nervous system controls basic involuntary body functions like breathing, digestion, heart rate, blood pressure, and body temperature. When this system malfunctions in ROHHAD, children can develop numerous problems.

These problems may include bradycardia (an abnormally slow heart rate), decreased or excessively high body temperature, icy cold hands and feet, profuse or absent sweating, abnormal blood pressure regulation, reduced sensitivity to pain or paradoxically excruciating pain when it is not expected, and gastrointestinal problems such as chronic constipation or diarrhea caused by altered gut motility.

Additional Complications

Beyond the hallmark symptoms, children with ROHHAD syndrome often develop additional complications. These can include mood and behavioral changes such as irritability, personality changes, or selective mutism. Some children experience cognitive challenges and developmental concerns, though others maintain normal intelligence.

Eye abnormalities are common, including strabismus (lazy eye), abnormal pupil responses, and astigmatism. Seizures may occur, particularly if sodium levels become severely imbalanced. The most serious complication is cardiorespiratory arrest, which can be fatal without immediate medical intervention.

Neuroendocrine Tumors

Approximately 40 to 50 percent of children with ROHHAD develop tumors called neuroblastic tumors, ganglioneuromas, or ganglioneuroblastomas. These tumors arise from neural crest tissue and can develop anywhere along the sympathetic nervous system, though they are most commonly found in the chest or abdomen. These tumors tend to be relatively benign and treatable with surgery.

Preventing ROHHAD Syndrome

Currently, there is no known way to prevent ROHHAD syndrome. Because the cause remains unknown and no genetic marker has been identified, doctors cannot predict which children will develop the condition or implement preventive measures.

However, awareness and early recognition of symptoms can lead to faster diagnosis, which is critical for improving outcomes. Parents and healthcare providers should be alert to the combination of rapid weight gain in a previously healthy child, especially when accompanied by other unusual symptoms like altered behavior, breathing problems during sleep, or signs of hormonal imbalance.

Because children with ROHHAD may develop tumors, regular screening is important once the diagnosis is made. Doctors typically recommend annual screening for neuroendocrine tumors using imaging tests. While this does not prevent tumor development, it allows for early detection and treatment.

How ROHHAD Syndrome Affects the Body

ROHHAD syndrome causes profound changes in how the body normally functions. Understanding these changes helps explain why the condition is so serious and affects so many different body systems.

The hypothalamus normally acts as the body's control center, coordinating with the pituitary gland to regulate hormones, body temperature, hunger, thirst, sleep patterns, and many other vital functions. In ROHHAD, hypothalamic dysfunction disrupts these carefully balanced systems. The body loses its ability to properly regulate metabolism, leading to obesity that persists despite diet and exercise efforts. Hormone production becomes erratic, affecting growth, thyroid function, stress responses, and sexual development.

The breathing problems in ROHHAD result from the brain's respiratory control center failing to respond appropriately to changes in blood oxygen and carbon dioxide levels. Normally, when carbon dioxide levels rise or oxygen levels fall, the brain automatically signals the body to breathe more deeply or rapidly. In children with ROHHAD, this automatic response is impaired or absent. During sleep, when breathing is entirely under automatic control, this becomes particularly dangerous. Without mechanical ventilation support, carbon dioxide can build up to dangerous levels, potentially causing seizures, brain damage, or death.

The autonomic nervous system dysfunction affects multiple organ systems simultaneously. The heart may beat too slowly, failing to pump adequate blood to the body. Blood vessels may not constrict or dilate properly, causing blood pressure problems. Temperature regulation fails, leaving children unable to sense or respond to hot or cold environments. The digestive system may not move food through properly, causing severe constipation or diarrhea. Pain perception becomes altered, so children may not feel injuries that should hurt or may experience severe pain from minor stimuli.

The connection between ROHHAD and tumor development remains unclear. Some researchers believe the tumors may be related to the autoimmune process that potentially causes ROHHAD, while others think they may be coincidental. The tumors typically arise from neural crest cells, which are cells that give rise to parts of the nervous system during fetal development.

Did you know?

  1. A case has been reported of a mature adult presenting with ROHHAD features, despite the condition typically only affecting children, with no previously documented survival beyond the third decade of life.
  2. Children with ROHHAD may have such altered pain perception that they feel little or no pain from injuries that should be extremely painful, while simultaneously experiencing excruciating pain from minor stimuli that shouldn't hurt.
  3. Approximately 95% of doctors will never encounter a case of ROHHAD during their entire medical career due to its extreme rarity, making diagnosis heavily dependent on specialized centers and parent advocacy.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for ROHHAD syndrome

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

ROHHAD syndrome

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Setmelanotide
  • Sponsor:Universitair Medisch Centrum Utrecht
See all 1 trials →filters applied: condition = ROHHAD syndrome

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).